台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

中化生

(1762)
可現股當沖
  • 股價
    47.30
  • 漲跌
    ▲1.10
  • 漲幅
    +2.38%
  • 成交量
    247
  • 產業
    上市 生技醫療類股
  • 250人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
中化生 (1762)籌碼相關-富邦-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-南京 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/09046.4500.0046.2002830.00%
2024/05/0700.00146.1546.45-1285-0.35%
2024/04/29145.6500.0045.8512890.35%
2024/04/22144.5000.0044.9513080.32%
2024/04/191044.5000.0043.80103093.23%
2024/04/15146.5000.0046.1513200.31%
2024/04/02049.6000.0048.7502930.00%
2024/03/29148.8500.0048.8512890.35%
2024/03/2800.00150.0050.00-1286-0.35%
2024/03/27049.7500.0049.7002830.00%
2024/03/26049.7000.0049.1002850.00%
2024/03/20150.3000.0050.2012840.35%
2024/03/15049.1000.0049.0502830.00%
2024/03/14049.25548.5049.25-5288-1.73%
2024/03/0800.00148.3048.30-1295-0.34%
2024/03/010.350.3000.0050.000.33620.08%
2024/02/2600.00150.3050.60-1425-0.24%
2024/02/21150.3000.0050.7014360.23%
2024/02/0200.00051.5051.1004350.00%
2024/02/0100.00351.5051.50-3435-0.69%
2024/01/2300.00151.9051.90-1447-0.22%
2024/01/22151.2000.0051.4014470.22%
2024/01/19151.1000.0051.2014490.22%
2024/01/1700.00151.3051.40-1444-0.23%
2024/01/121053.5000.0053.40104332.30%
2024/01/1000.00454.9054.50-4439-0.91%
2023/12/190.257.4000.0057.000.24690.03%
2023/12/18357.8700.0057.4034750.63%
2023/12/1100.00357.5057.10-3490-0.61%
2023/12/0700.00158.1058.00-1490-0.20%
2023/11/30158.6000.0058.5014660.21%
2023/11/29258.90159.0059.0014670.21%
2023/11/28359.60159.3059.2024660.43%
2023/11/2700.00262.6061.30-2438-0.46%
2023/11/24157.70058.3057.9013840.26%
2023/11/21357.0700.0057.1033800.79%
2023/11/1700.00256.0056.00-2366-0.55%
2023/11/14154.5000.0054.5013900.26%
2023/11/08155.10155.1055.5004140.00%
2023/11/0600.00154.7055.10-1438-0.23%
2023/11/0300.002354.7854.50-23463-4.97%
2023/11/02154.5000.0054.5014700.21%
2023/10/272554.8400.0054.60255084.92%
2023/10/25154.4000.0054.0015400.18%
2023/10/23353.5700.0053.2035620.53%
2023/10/20053.0000.0053.0005710.00%
2023/10/1300.00157.5055.90-1631-0.16%
2023/10/03062.9000.0058.3008380.00%
2023/10/0200.002058.9859.00-20851-2.35%
2023/09/2600.00159.2059.20-1975-0.10%
2023/09/2500.00159.9060.10-11,002-0.10%
2023/09/2200.00258.9059.00-21,037-0.19%
2023/09/21260.00260.1559.7001,0770.00%
2023/09/182062.4400.0062.40201,2031.66%
2023/09/15261.4000.0061.8021,2040.17%
2023/09/14661.5500.0061.6061,2100.50%
2023/09/110.361.7000.0060.500.31,2360.02%
2023/09/0600.000.161.1060.80-0.11,349-0.01%
2023/08/31162.6000.0061.9011,4290.07%
2023/08/30162.7000.0062.6011,4400.07%
2023/08/280.162.30062.5061.800.11,4860.01%
2023/08/24162.80162.4062.4001,5730.00%
2023/08/22164.10163.0063.0001,6190.00%
2023/08/1600.00364.9065.50-31,699-0.18%
2023/08/15066.6000.0066.4001,7750.00%
2023/08/14565.0000.0065.6051,8120.28%
2023/08/11168.40167.5067.5001,8720.00%
2023/08/09470.35269.8570.0021,9530.10%
2023/08/08271.45171.5071.5012,0110.05%
2023/08/021.673.63272.7572.80-0.42,342-0.02%
2023/08/01173.6000.0073.9012,3900.04%
2023/07/31275.25774.0373.60-52,435-0.21%
2023/07/2800.00676.2276.20-62,494-0.24%
2023/07/2700.00477.5377.30-42,506-0.16%
2023/07/263.276.92176.1076.102.22,5350.09%
2023/07/24577.38177.0077.0042,6470.15%
2023/07/2100.00079.6078.6002,6680.00%
2023/07/20179.30179.5079.5002,6740.00%
2023/07/19178.20180.5079.3002,6960.00%
2023/07/18279.551178.1478.00-92,749-0.33%
2023/07/17380.40679.9780.30-32,781-0.11%
2023/07/14679.98180.0080.3052,8150.18%
2023/07/13179.10178.5078.5002,8580.00%
2023/07/12479.633.278.4878.400.82,9360.03%
2023/07/1120.481.731081.8081.3010.42,9780.35%
2023/07/10189.00589.7090.30-42,984-0.13%
2023/07/07190.60790.2989.90-63,033-0.20%
2023/07/06392.30392.6091.6003,1010.00%
2023/07/05494.101394.0093.20-93,116-0.29%
2023/07/04394.23295.9094.8013,1420.03%
2023/07/03393.00792.9392.90-43,173-0.13%
2023/06/3000.00192.5092.40-13,197-0.03%
2023/06/29591.84391.9091.8023,3240.06%
2023/06/28490.8500.0091.8043,4260.12%
2023/06/271288.97389.1089.3093,4260.26%
2023/06/26285.9000.0085.0023,4580.06%
2023/06/21186.00486.8886.50-33,473-0.09%
2023/06/20186.60186.5086.5003,4790.00%
2023/06/19186.60186.2086.2003,5030.00%
2023/06/15285.45585.3085.70-33,528-0.09%
2023/06/141986.22185.2085.20183,5570.51%
2023/06/1300.00783.8984.30-73,625-0.19%
2023/06/121485.16284.0084.00123,7070.32%
2023/06/0900.00291.1592.80-23,877-0.05%
2023/06/08289.15387.7787.70-13,955-0.03%
2023/06/07389.83489.6389.50-13,957-0.03%
2023/06/05188.201288.3489.40-114,084-0.27%
2023/06/021088.29387.8787.6074,1150.17%
2023/06/01189.00189.1089.1004,1530.00%
2023/05/31289.00190.0088.8014,2260.02%
2023/05/30191.80288.8089.00-14,266-0.02%
2023/05/29191.70191.8091.8004,2270.00%
2023/05/26192.80190.7090.7004,2230.00%
2023/05/25194.30192.8092.8004,2280.00%
2023/05/24194.3000.0094.3014,2400.02%
2023/05/23295.15195.0095.0014,2210.02%
2023/05/22193.30694.7095.40-54,218-0.12%
2023/05/19794.36493.5592.5034,1840.07%
2023/05/181399.551299.5997.8014,1150.02%
2023/05/17798.29798.6998.5004,1000.00%
2023/05/161195.781395.8496.60-24,034-0.05%
2023/05/151191.87393.0093.0084,0090.20%
2023/05/123795.853695.0393.8014,0280.02%
2023/05/113795.853695.0394.9013,9510.03%
2023/05/10298.954100.80102.50-23,756-0.05%
2023/05/092.594.69492.9593.20-1.53,639-0.04%
2023/05/08197.80395.9795.90-23,622-0.06%
2023/05/05198.302099.0798.60-193,581-0.53%
2023/05/04196.80296.8598.10-13,529-0.03%
2023/05/03395.40295.3095.7013,4470.03%
2023/05/02496.2500.0095.7043,4320.12%
2023/04/28794.47993.8095.60-23,399-0.06%
2023/04/272392.042290.9691.8013,3190.03%
2023/04/26789.26388.0389.9043,2700.12%
2023/04/25189.60288.0588.40-13,244-0.03%
2023/04/24289.25289.3089.2003,2280.00%
2023/04/21688.82587.6087.4013,2280.03%
2023/04/20193.404.190.5790.20-3.13,164-0.10%
2023/04/19993.61393.5793.9063,1240.19%
2023/04/185.193.93793.1194.40-1.93,086-0.06%
2023/04/1700.000.893.5693.10-0.83,038-0.03%
2023/04/1416.591.2520.190.8091.50-3.62,955-0.12%
2023/04/13185.30586.1088.00-42,870-0.14%
2023/04/12284.05183.8084.0012,7950.04%
2023/04/1100.00380.3081.80-32,768-0.11%
2023/04/10282.00181.6082.7012,7970.04%
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章